Ocugen director Manish Potti not standing for re-election; board adds Marna Whittington, new CAO employment deal

Ocugen, Inc.

Manish Potti, Class II director, will not stand for re-election at 2022 annual meeting; no disagreement cited.
Board expanded from 7 to 8; Marna Whittington appointed Class II director effective March 21, 2022; board to shrink to 7 after annual meeting.
Dr. Whittington receives initial option grant with grant date fair value $285,000, vesting over three years.
CAO Jessica Crespo enters amended employment agreement with base salary $375,000 and target bonus 40% of base salary.
Crespo awarded stock option ($225,000 fair value) and RSUs ($75,000 fair value), both vesting over three years.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Manish Potti

Class II Director

OCGN · Ocugen, Inc.

Filed: March 23, 2022, 7:59 PM ET

On March 17, 2022, Manish Potti, a member of the Board of Directors (the “Board”) of Ocugen, Inc. (the “Company”), notified the Board that he will not stand for re-election as a Class II director at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”), and therefore, will no longer serve as a director of the Company or on any committee of the Board, effective as of the Annual Meeting.

Appointed

Marna Whittington

Class II Director

OCGN · Ocugen, Inc.

Effective: 2022-03-21
Filed: March 23, 2022, 7:59 PM ET

On March 17, 2022, the Board increased the size of the Board from seven to eight members, and appointed Marna Whittington, Ph.D. as a Class II director, effective March 21, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Manish Potti departed as Class II Director at Ocugen, Inc..

Action: not stand for re-election
Role: Class II Director

Exact text from the filing

On March 17, 2022, Manish Potti, a member of the Board of Directors (the “Board”) of Ocugen, Inc. (the “Company”), notified the Board that he will not stand for re-election as a Class II director at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”), and therefore, will no longer serve as a director of the Company or on any committee of the Board, effective as of the Annual Meeting.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Marna Whittington was appointed as Class II Director at Ocugen, Inc..

Action: appointed
Role: Class II Director

Exact text from the filing

On March 17, 2022, the Board increased the size of the Board from seven to eight members, and appointed Marna Whittington, Ph.D. as a Class II director, effective March 21, 2022.

View on SEC.gov

Ocugen, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-036781

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.